Biosenta Inc.
ZRO
CNSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.85M | -1.82M | -1.71M | -1.64M | -5.01M |
| Total Depreciation and Amortization | 1.80K | 1.90K | 2.70K | 2.20K | 1.70K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.23M | 1.11M | 1.04M | 859.10K | 4.03M |
| Change in Net Operating Assets | 325.40K | 321.50K | 224.40K | 202.70K | 356.30K |
| Cash from Operations | -297.30K | -386.10K | -447.50K | -573.10K | -626.50K |
| Capital Expenditure | -18.50K | -18.50K | -18.50K | -- | -11.60K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -18.50K | -18.50K | -18.50K | -- | -11.60K |
| Total Debt Issued | 384.70K | 256.10K | 244.70K | 0.00 | 117.60K |
| Total Debt Repaid | 56.00K | -304.00K | -304.00K | -304.00K | -360.00K |
| Issuance of Common Stock | -- | 240.10K | 405.40K | 740.10K | 740.10K |
| Repurchase of Common Stock | -359.90K | -359.90K | -359.90K | -359.90K | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 359.90K | 719.70K | 554.10K | 705.70K | 345.80K |
| Cash from Financing | 315.50K | 397.40K | 391.60K | 574.30K | 620.80K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -500.00 | -7.40K | -74.50K | 1.10K | -17.20K |